Mechanistic investigation of Liujing Toutong tablet in the treatment of cerebral ischemia–reperfusion injury in rats by the integration of serum pharmacochemistry and metabolomics
Animal Models and Experimental Medicine · 2026-06 · 9 (6) · 1105-1125
DOI: 10.1002/ame2.70203 ↗Kurz gefasst
Fachartikel in der Zeitschrift Animal Models and Experimental Medicine, online erschienen am 28.05.2026. Verfasst von Zihan Yu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Shanxi Key Laboratory of Chinese Herbal Medicine Processing, School of Chinese Medicine and Food Engineering, Shanxi University of Chinese Medicine, …. Hauptthemen laut MEDLINE: Reperfusion Injury, Drugs, Chinese Herbal, Metabolomics, Brain Ischemia. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Key R&D Project of Shanxi Province, The Opening Project of the Zhejiang Provincial Preponderant and Characteristic Subject of Key University (Traditional Chinese Pharmacology), Zhejiang Chinese Medical University.
Abstract (Originalsprache)
Background
Liujing Toutong tablet (LTT) is a traditional Chinese patent medicine. Previous studies have demonstrated that LTT exerts a protective effect in permanent cerebral ischemia and cerebral ischemia–reperfusion injury (CIRI). However, the active compounds and underlying mechanisms remain unclear. This investigation aimed to integrate the analyses of serum pharmacochemistry, network pharmacology, and metabolomics to elucidate the therapeutic effects of LTT on CIRI.
Methods
The therapeutic effects of LTT were evaluated in the CIRI rat model, which was induced using the thread embolism method. The prototype active compounds of LTT absorbed into the serum (LPCs) were identified using ultra‐performance liquid chromatography‐quadrupole/orbitrap high‐resolution mass spectrometry (UPLC‐Q‐Exactive‐Orbitrap/MS). Potential targets of LPCs were determined using network pharmacological analysis. A combination of metabolomics and network pharmacology was employed to identify upstream key targets and downstream endogenous metabolites. The predicted mechanisms were then verified by molecular docking. Finally, key targets and signaling pathways were examined using enzyme‐linked immunosorbent assay (ELISA) and Western blot.
Results
A total of 27 LPCs were identified as the active ingredients. Furthermore, glycerophospholipid and arachidonic acid (AA) metabolism were also identified, with PTGS2, ALOX5, and AchE as the upstream key targets, and phosphorylcholine, AA, phosphatidate (PA), hosphatidylcholines (PCs), and lysophosphatidylcholines (LysoPCs) as the core endogenous metabolites. Additionally, LPCs binding with these key targets might reduce the inflammatory response via nuclear factor Kappa‐B (NF‐κB) signaling pathway.
Conclusion
LTT may effectively alleviate symptoms of CIRI by acting on PTGS2, ALOX5, and AchE, improving the glycerophospholipid and AA metabolism and reducing the inflammatory response by inhibiting NF‐κB signaling pathway‐related proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Shanxi Key Laboratory of Chinese Herbal Medicine Processing, School of Chinese Medicine and Food Engineering, Shanxi University of Chinese Medicine, Jinzhong, China.
- School of Pharmacy, Zhejiang Chinese Medical University, Hangzhou, China.
ORCID-Profile: Zihan Yu
Förderung
- The Key R&D Project of Shanxi Province
- The Opening Project of the Zhejiang Provincial Preponderant and Characteristic Subject of Key University (Traditional Chinese Pharmacology)
- Zhejiang Chinese Medical University
- The Special Fund for Science and Technology Innovation Teams of Shanxi Province
- The Science and Technology Innovation Program of Shanxi University of Chinese Medicine
- The Shanxi Province Basic Research Program
Zitieren
APA
Yu, Z., Pei, K., Wang, X., Li, W., Li, H., Xie, W., Meng, X., Zhao, T., Ning, Y., Liu, H., & He, W. (2026). Mechanistic investigation of Liujing Toutong tablet in the treatment of cerebral ischemia–reperfusion injury in rats by the integration of serum pharmacochemistry and metabolomics. Animal Models and Experimental Medicine, 9(6), 1105-1125. https://doi.org/10.1002/ame2.70203
Vancouver
Yu Z, Pei K, Wang X, Li W, Li H, Xie W, et al. Mechanistic investigation of Liujing Toutong tablet in the treatment of cerebral ischemia–reperfusion injury in rats by the integration of serum pharmacochemistry and metabolomics. Animal Models and Experimental Medicine. 2026;9(6):1105-1125. doi:10.1002/ame2.70203
BibTeX
@article{Yu2026,
author = {Yu, Zihan and Pei, Ke and Wang, Xiulin and Li, Wenling and Li, Hongchang and Xie, Wangyang and Meng, Xianglong and Zhao, Tingting and Ning, Yan and Liu, Haixin and He, Wenbin},
title = {Mechanistic investigation of Liujing Toutong tablet in the treatment of cerebral ischemia–reperfusion injury in rats by the integration of serum pharmacochemistry and metabolomics},
journal = {Animal Models and Experimental Medicine},
year = {2026},
volume = {9},
number = {6},
pages = {1105--1125},
doi = {10.1002/ame2.70203}
}
EUVIMED